Apellis Pharmaceuticals Inc - Plans to Seek Re-Examination and Expects a Final Opinion in Q4 of 2024
Apellis Pharmaceuticals公司計劃尋求再審,並預計於2024年第四季度得出最終意見。
Apellis Pharmaceuticals Inc - Plans to Seek Re-Examination and Expects a Final Opinion in Q4 of 2024
Apellis Pharmaceuticals公司計劃尋求再審,並預計於2024年第四季度得出最終意見。
譯文內容由第三人軟體翻譯。